Constitutive NO synthase regulates the Na+/Ca2+ exchanger in human T cells: Role of [Ca2+]i and tyrosine phosphorylation

Journal of Cellular Biochemistry

Volumn 89, Issue 5, 2003, Pages 1030-1043

  Kiang, Juliann G ^a,b,c   McClain, David E ^d   Warke, Vishal G ^a   Krishnan, Sandeep ^a   Tsokos, George C ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

Ca2+; CD95; Fas; Heat stress; Lymphocytes; Na+ Ca2+ exchanger; NO synthase; T cells; Tyrosine phosphorylation

Indexed keywords

FAS ANTIGEN; N(G) NITROARGININE; N6 (1 IMINOETHYL)LYSINE; NITRIC OXIDE SYNTHASE;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; HEAT STRESS; HEATING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SODIUM CALCIUM EXCHANGE; T LYMPHOCYTE;

AMILORIDE; ANTIGENS, CD95; CALCIUM; CELL MEMBRANE; ENZYME INHIBITORS; HEAT STRESS DISORDERS; HUMANS; JURKAT CELLS; KINETICS; LYSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PENICILLAMINE; PHOSPHORYLATION; PRECIPITIN TESTS; SODIUM; SODIUM-CALCIUM EXCHANGER; T-LYMPHOCYTES; TYROSINE;

EID: 0041767497     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10564     Document Type: Article

References (42)

1. Chang WJ, Iannaccone ST, Lau KS, Masters BS, McCabe TJ, McMillan K, Padre RC, Spencer MJ, Tidball JG, Stull JT. 1996. Neuronal nitric oxide synthase and dystrophin-dificient muscular dystrophy. Poc Natl Acad Sci USA 93:9142-9147.
2. Cho JG, Balasubramanyam M, Chernaya G, Gardner JP, Aviv A, Reeves JP, Dargis PG, Christian EP. 1997. Oligomycin inhibits store-operated channels by a mechanism independent of its effects on mitochondrial ATP. Biochem J 324:971-980.
3. Dawson TMM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH. 1993. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 90:9808-9812.
4. i. J Investig Med 44:144-153.
5. Fehsel K, Kroncke KD, Kolb-Bachofen V. 1995. The action of NO and its role in autoimmune diabetes mellitus. Res Immunol 146:711-715.
6. Forstermann U, Boissel J, Kleinert H. 1998. Expressional control of the constitutive isoforms of nitric oxide synthase (NOSI and NOSIII). FASEB J 12:773-790.
7. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC. 1998. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392:821-824.
8. Gaston B. 1999. Nitric oxide and thio groups. Biochim Biophys Acta 1411:323-333.
9. Hueber AO, Zornig M, Chautan M, Evan G. 2000. A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts. J Biol Chem 275:10453-10462.
10. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269.
11. 2+ affinity. J Biol Chem 275:38571-38580.
12. Kelly E, Shah NS, Morgan NN, Watkins SC, Peitzman AB, Billiar TR. 1997. Physiologic and molecular characterization of the role of nitric oxide in hemorrhagic shock: Evidence that type II nitric oxide synthase does not regulate vascular decompensation. Shock 7:157-163.
13. 2+] in human epidermoid A-431 cells. Eur J Pharmacol (Mol Pharmacol Section) 207:287-296.
14. Kiang JG. 2003. Genistein inhibits herbimycin A-induced overexpression of inducible heat shock protein 70 kDa. Mol Cell Biochem 245:191-199.
15. i, cAMP on inositol trisphosphate in human epidermoid A-431 cells. Am J Physiol 264:C1561-C1569.
16. 2+] in human colon carcinoma T84 cells. Chin J Physiol 42:153-159.
17. Kiang JG, Tsokos GC. 1998. Heat shock protein 70 kDa: Molecular biology, biochemistry, and physiology. Pharmacol Ther 80:183-201.
18. 2+ exchange in human epidermoid A-431 cells. Am J Physiol 263:C30-C38.
19. i or cAMP. Am J Physiol 265: C104-C114.
20. i and protects human epidermoid A-431 cells after chemical hypoxia. Toxicol Appl Pharmacol 149:185-194.
21. 2+, PKC, and PKA in human intestinal epithelial T84 cells. Am J Physiol 282:G415-G423.
22. Knowles RG, Palacios M, Palmer RM, Moncada JS. 1989. Formation of nitric oxide from L-arginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA 86:5159-5162.
23. 2+ exchanger binds to the cytoskeletal protein ankyrin. J Biol Chem 268:11489-11491.
24. Liew FY, Cox FE. 1991. Nonspecific defense mechanism: The role of nitric oxide. Immunol Today 12:A17.
25. Liossis S-NC, Ding XZ, Kiang JG, Tsokos GC. 1997. Overexpression of the heat shock protein 70 enhances the TCR/CD3- and Fas/Apo/CD95-mediated apoptotic cell death in Jurkat cells. J Immunol 158:5668-5675.
26. Ma H-T, Venkatachalam K, Parys JB, Gill DL. 2002. Modification of store-operated channel coupling and inositol trisphosphate receptor function by 2-aminoethoxydiphenyl borate in DT40 lymphocytes. J Biol Chem 277:6915-6922.
27. Malen PL, Chapman PF. 1997. Nitric oxide facilitates long-term potentiation, but not long-term depression. J Neurosci 17:2645-2651.
28. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, Wahl SM. 1993. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178:749-754.
29. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY. 1996. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184:1519-1524.
30. Moncada S, Palmer RMJ, Higgs A. 1991. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
31. 2+ exchangers. Implications for function and expression. J Biol Chem 276:19603-19609.
32. 2+ antiport in the mammalian heart. J Exp Biol 196:375-388.
33. Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WF. 1996. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epthelium in inflammatory bowel disease. Gastroentorology 111:871-885.
34. Stefano GB, Goumon Y, Bilfinger TV, Welters ID, Cadet P. 2000. Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor. Prog Neurobiol 60:513-530.
35. Stricker NL, Christopherson KS, Yi BA, Schatz PJ, Raab RW, Dawes G, Bassett DE, Jr, Bredt DS, Li M. 1997. PDZ domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences. Nat Biotechnol 15:336-342.
36. Stuehr DJ. 1999. Mammalian nitric oxide synthases. Biochim Biophys Acta 1411:217-230.
37. Szabo C, Thiemermann C. 1994. Invited opinion: Role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock 2:145-155.
38. Thiemermann C, Szabo C, Mitchell JA, Vane JR. 1993. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 90:261-271.
39. Tochio H, Ohki S, Zhang Q, Li M, Zhang M. 1998. Solution structure of a protein inhibitor of neuronal nitric oxide synthase. Nat Struet Biol 5:965-969.
40. Venema VJ, Ju H, Zou R, Venema RC. 1997. Interaction of neuronal nitric oxide synthase with carveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 272:28187-28190.
41. 2+ pool depletion in thapsigargin-resistant cells. J Biol Chem 272:6440-6447.
42. Yankee TM, Draves KE, Ewings MK, Clark EA, Graves JD. 2001. CD95/Fas induces cleavage of the GrpL/Gads adaptor and desensitization of antigen receptor signaling. Proc Natl Acad Sci USA 98:6789-6793.